E-ISSN 2651-3455 (Online) | ISSN 2630-5593 (Print)

Quick Search




The Anatolian Journal of Family Medicine Prevalence of Non Alcoholic Fatty Liver Disease in patients with Parkinson Disease [anatol j fm]
anatol j fm. 2019; 2(1): 38-40 | DOI: 10.5505/anatoljfm.2018.58066

Prevalence of Non Alcoholic Fatty Liver Disease in patients with Parkinson Disease

Selahattin Vural1, Muhammed Ali Ayvaz2, Tuğrul Kesicioğlu1, Selim Turfan3, Arzu Ayraler4, Ahmet Cumhur Dülger2
1Department Of General Surgery, Giresun University, Giresun, Turkey
2Department of Gastroenterology, Giresun University, Giresun, Turkey
3Department of Emergency Medicine, Giresun University, Giresun, Turkey
4Departmant of Family Medicine, Giresun University, Giresun, Turkey

INTRODUCTION: Non alcoholic fatty liver disease (NAFLD) has presented as the most common cause of chronic liver disease in the Western world. Parkinson disease (PD) is the second most common non-demyelinizan neurologic disase and its incidence is steadily increasing in the world. Our study aims to analyze the prevalence of ultrasonography-proven NAFLD among the PD patients.
METHODS: A retrospective chart review was performed to identify PD patients who had at least two visits in the Liver Clinic from January 2017 to May 2018. Thus, 124 consecutive patients (the mean age 74,2±11,9years; 65 female) with PD was longitudinally screened for NAFLD which were diagnosed according to ultrasonographic criteria. Control subjects (65 subjects, mean age was 68±3.4 years; 35 female) were selected from age-matched eldely subjects. Demographic and laboratory data, concurrent statin use and results of hepatobiliary ultrasonography were collected. Patients with history of chronic liver disase, liver transplant, past alcohol use or not enough data to stage NAFLD were excluded. Data analyzed using Pearson’s chi-squared test with the Stata software.
RESULTS: Nonalcoholic fatty liver disease prevalence was significantly lower in the PD group than in the age -matched control group (21% vs. 36%, P<0.05). In multiple logistic regression analyses using baseline factors, statin use (P=0.04) and elevated Hb A 1 C (P<0.001), baseline fasting glucose below than 100 mg/dL (P=0.03), and elevated ALT levels (P<0.001) were independently associated with NAFLD.
DISCUSSION AND CONCLUSION: While additional studies in large populations are needed to investigate the correlation between PD and NAFLD, further exploration of PD -related metabolic liver disease clinically appears warranted.

Keywords: NAFLD, PARKİNSON, FATTY, LİVER

Selahattin Vural, Muhammed Ali Ayvaz, Tuğrul Kesicioğlu, Selim Turfan, Arzu Ayraler, Ahmet Cumhur Dülger. Prevalence of Non Alcoholic Fatty Liver Disease in patients with Parkinson Disease. anatol j fm. 2019; 2(1): 38-40

Corresponding Author: Selahattin Vural, Türkiye
LookUs & Online Makale